Please try another search
For the 39 weeks ended 02 December 2017, Jean Coutu Group PJC Inc revenues increased 3% to C$2.25B. Net income decreased 11% to C$135.4M. Revenues reflect Comp. Store Sales (Growth - %) -Pharmacy increase from 1.9 to 6.2%, Value of Retail Sales increase of 5% to C$3.39B. Net income was offset by Generic Drugs segment income decrease of 72% to C$16M. Dividend per share increased from C$0.36 to C$0.39.
Period Ending: | Dec 02, 2017 | Sep 02, 2017 | Jun 03, 2017 | Mar 04, 2017 |
---|---|---|---|---|
Total Revenue | 758.9 | 744.3 | 750.4 | 789.4 |
Gross Profit | 148.8 | 146 | 150.9 | 156.8 |
Operating Income | 56.4 | 64.6 | 61.5 | 65.7 |
Net Income | 42.1 | 47.8 | 45.5 | 47.8 |
Period Ending: | Dec 02, 2017 | Sep 02, 2017 | Jun 03, 2017 | Mar 04, 2017 |
---|---|---|---|---|
Total Assets | 1580.7 | 1545.1 | 1504.3 | 1524.1 |
Total Liabilities | 304.4 | 287.3 | 270.5 | 314 |
Total Equity | 1276.3 | 1257.8 | 1233.8 | 1210.1 |
Period Ending: | Dec 02, 2017 | Sep 02, 2017 | Jun 03, 2017 | Mar 04, 2017 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | 165.5 | 106.1 | 39 | 212.3 |
Cash From Investing Activities | -19.1 | -8.8 | -6.6 | -19.2 |
Cash From Financing Activities | -69.7 | -45.9 | -22 | -113.6 |
Net Change in Cash | 76.7 | 51.4 | 10.4 | 78.6 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review